Agios Pharmaceuticals (AGIO) is down -47.4%, or -$21.54 to $23.95.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGIO:
- Morning Movers: Semrush skyrockets after deal to be bought by Adobe
- Agios reports RISE UP Phase 3 trial of mitapivat met primary endpoint
- Agios Pharmaceuticals announces new data on mitapivat
- Agios Pharmaceuticals’ Earnings Call: Growth and Challenges
- Agios Pharmaceuticals Reports Q3 2025 Financial Results